Clinical Research Scientist
Mercor, New York, NY, United States
About the Job
Mercor connects elite creative and technical talent with leading AI research labs. Headquartered in San Francisco, our investors include Benchmark, General Catalyst, Peter Thiel, Adam D'Angelo, Larry Summers, and Jack Dorsey.
Position
PhD-level Consultant
Type
Contract
Compensation
$110–$135 per hour
Location
United States or United Kingdom
Role Responsibilities
Design and execute in vivo studies linking molecular mechanisms to disease-relevant phenotypes.
Develop biomarker strategies from target engagement to clinical response, considering sample collection and assay performance.
Evaluate formulation and delivery approaches for tissue access across modalities.
Build exposure-activity relationships from in vivo datasets to inform clinical predictions.
Determine safe and pharmacologically relevant starting doses for human studies, including cross-species scaling.
Conduct exposure-response analysis and model-informed dose optimization.
Qualifications
PhD, MD, or PharmD in pharmacology, pharmaceutical sciences, biostatistics, quantitative biology, or related field.
5+ years of industry experience in pharma, biotech, or CRO environments.
Based in the United States or United Kingdom.
Experience supporting at least one program from late preclinical stages through IND or into early clinical development.
Strong communication skills for technical and non-technical audiences.
#J-18808-Ljbffr
Mercor connects elite creative and technical talent with leading AI research labs. Headquartered in San Francisco, our investors include Benchmark, General Catalyst, Peter Thiel, Adam D'Angelo, Larry Summers, and Jack Dorsey.
Position
PhD-level Consultant
Type
Contract
Compensation
$110–$135 per hour
Location
United States or United Kingdom
Role Responsibilities
Design and execute in vivo studies linking molecular mechanisms to disease-relevant phenotypes.
Develop biomarker strategies from target engagement to clinical response, considering sample collection and assay performance.
Evaluate formulation and delivery approaches for tissue access across modalities.
Build exposure-activity relationships from in vivo datasets to inform clinical predictions.
Determine safe and pharmacologically relevant starting doses for human studies, including cross-species scaling.
Conduct exposure-response analysis and model-informed dose optimization.
Qualifications
PhD, MD, or PharmD in pharmacology, pharmaceutical sciences, biostatistics, quantitative biology, or related field.
5+ years of industry experience in pharma, biotech, or CRO environments.
Based in the United States or United Kingdom.
Experience supporting at least one program from late preclinical stages through IND or into early clinical development.
Strong communication skills for technical and non-technical audiences.
#J-18808-Ljbffr